Healthcare / Medical Care FacilitiesHKSE
$0.78
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 21%
FCF escenarios
weak_data · normalized FCF $90.8M · quality 57.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$296M
P/E
11.1x
↓EV/EBITDA
-0.1x
↓ROE
3.4%
↑Gross Margin
45.8%
↓Debt/Equity
0.17
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-16.9%
FCF CAGR
-25.5%
FCF margin
14.1%
FCF / Net income
3.45x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $644.4M · net income $26.3M · FCF $90.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $644.4M | $644.4M | $590.8M | $1.00B | $1.12B |
| Net Income | $26.3M | $26.3M | $24.2M | $180.8M | $375.3M |
| EBITDA | $104.2M | $104.2M | $102.8M | $321.9M | $511.3M |
| EPS | 0.07 | 0.07 | 0.06 | 0.48 | 0.99 |
| Gross Margin | 45.8% | 45.8% | 45.7% | 59.2% | 58.8% |
| Operating Margin | 3.7% | 3.7% | 1.1% | 24.6% | 37.5% |
| Net Margin | 4.1% | 4.1% | 4.1% | 18.1% | 33.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.17 | 0.17 | 0.19 | 0.23 | 0.25 |
| Current Ratio | 3.14 | 3.14 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $90.8M | $90.8M | $-26.3M | $580.2M | $219.3M |
| Returns | |||||
| ROE | 3.4% | 3.4% | 3.2% | 22.4% | 50.6% |
| Valuation | |||||
| P/E | 11.14 | 11.14 | 16.72 | 3.91 | 1.70 |
| EV/EBITDA | -0.09 | -0.09 | 0.61 | 0.77 | 1.09 |
| P/B | 0.38 | 0.38 | 0.53 | 0.87 | 0.86 |
| Growth & Yield | |||||
| Revenue Growth | 9.1% | 9.1% | -41.0% | -10.7% | — |
| EPS Growth | 7.8% | 7.8% | -86.6% | -51.9% | — |
| Dividend Yield | 3.9% | 3.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
0.1%
EPS terminal req.
$0.07
Spread vs growth
7.7%
5Y implied EPS CAGR
3.9%
EPS terminal req.
$0.08
Spread vs growth
3.9%
10Y implied EPS CAGR
6.9%
EPS terminal req.
$0.13
Spread vs growth
0.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.1%
Start / end P/E
12.7x → 11.3x
EPS bridge
0.06 → 0.07
Residual
-0.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.